Abstract:Introduction: Human studies show congenital heart disease (CHD) has a complex non-Mendelian genetic etiology. We previously conducted a recessive N-ethyl-N-nitrosourea (ENU) mouse mutagenesis screen using fetal ultrasound and recovered over 150 recessive mutations causing CHD. In the present study, we conducted a sensitized screen with driver mutations to recover dominant mutations causing CHD. We hypothesize this dominant screen can help to elucidate the complex genetic architecture of CHD. Methods: G1 males with heterozygous ENU induced mutations were mated to females harboring heterozygous “driver” mutation in Kif7, Anks6, or Sap130 that can cause CHD when homozygous. The resulting G2 offspring were screened for CHD by fetal ultrasound. Mutations in G1 males were identified by whole exome sequencing and the G2 offspring were genotyped using Ion Torrent sequencing. Linkage analysis was conducted to identify the CHD causing mutation. Results: We found 9.3% of the G1 pedigrees (n=551) yielded CHD mutants, similar to the 8.2% observed in the previous recessive screen. However, only 2.5 mutants were recovered per line vs. 4.5 in the recessive screen despite having screened similar number of embryos, supporting non-Mendelian genetics in the dominant screen. Genotype-phenotype analysis revealed only 32%, 45%, and 55% of the CHD mutants recovered carried the Kif7, Anks6, or Sap130 driver mutations, respectively, suggesting the driver mutations are not required for CHD pathogenesis. For mouse line 4142 with DORV/OA, we identified a heterozygous p21/Rac-activated kinase 2 ( Pak2) mutation as disease causing (p=4.8e-12). CHD penetrance was 83% among Pak2 +/m embryos. Among surviving 4142 G2 offspring, only 14% have the Pak2 mutation vs. 50% expected. We observed 75% of the surviving Pak2 mutant mice also carry a mutation in Zbtb2, a gene identified to regulate p21, suggesting this may act as a protective modifier. Conclusion: We showed the feasibility of using mouse mutagenesis to recover dominant mutations causing CHD, and showed for the first time a role for Pak2 in CHD. These findings demonstrate that the genetic diversity created by ENU mutagenesis can provide the genomic context to investigate the complex genetics and genetic architecture of CHD.

International Awards

Gestational 1-Nitropyrene Exposure Causes Gender-Specific Impairments on Postnatal Growth and Neurobehavioral Development in Mice

Large-scale Screening of Disease Model Through ENU Mutagenesis in Mice

Implications for tooth development on ENU-induced ectodermal dysplasia mice

Neuromedin U receptor 2-deficient mice display differential responses in sensory perception, stress, and feeding.

Null Mutation Of The Endothelin Receptor Type B Gene Causes Embryonic Death In The Gk Rat

Expression of expanded GGC repeats within NOTCH2NLC causes behavioral deficits and neurodegeneration in a mouse model of neuronal intranuclear inclusion disease

Rapid identification of a disease allele in mouse through whole genome sequencing and bulk segregation analysis.

Germline Saturation Mutagenesis Induces Skeletal Phenotypes in Mice

[Optimization Ofpig-Agene Mutation in Rats and Assessment of Time-dependent and Dose-response Relationship of N-ethyl-N-nitrosourea].

Massively Parallel Sequencing Identifies The Gene Megf8 With Enu-Induced Mutation Causing Heterotaxy

Abstract 16596: Dominant Mouse Mutagenesis Screen Unveils a Complex Genetic Architecture for Congenital Heart Disease

Targeted Mutation (R100W) of the Gene Encoding NGF Leads to Deficits in the Peripheral Sensory Nervous System.

NHE8 Is Essential for RPE Cell Polarity and Photoreceptor Survival

Identification of a Novel Point Mutation of Mouse Atp2b2 Induced by N-Ethyl-N-Nitrosourea Mutagenesis

Identification of a Novel ENU-Induced Mutation in Mouse Tbx1 Linked to Human DiGeorge Syndrome

The Mouse MC13 Mutant Is a Novel ENU Mutation in Collagen Type II, Alpha 1

Retina restored and brain abnormalities ameliorated by single-copy knock-in of human NR2E1 in null mice

Identification. of A Novel Point Mutation of Mouse Proto-Oncogene C-Kit Through N-Ethyl-N-Nitrosourea Mutagenesis

Patient-specific mutation of Dync1h1 in mice causes brain and behavioral deficits

Unraveling Innate Immunity Using Large Scale N‐ethyl‐N‐nitrosourea Mutagenesis